Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Baxter
Colorcon
Dow
McKesson

Last Updated: November 29, 2022

CLINICAL TRIALS PROFILE FOR THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Theophylline 0.08% And Dextrose 5% In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000575 ↗ Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed CAMP Steering Committee Phase 3 1991-09-01 The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗ Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1991-09-01 The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000575 ↗ Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed Johns Hopkins Bloomberg School of Public Health Phase 3 1991-09-01 The purpose of this study is to evaluate the long term effects of anti-inflammatory therapy compared to bronchodilator therapy on the course of asthma, particularly on lung function and bronchial hyperresponsiveness, and on physical and psychosocial growth and development.
NCT00000577 ↗ Asthma Clinical Research Network (ACRN) Withdrawn National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1993-09-01 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000577 ↗ Asthma Clinical Research Network (ACRN) Withdrawn Milton S. Hershey Medical Center Phase 3 1993-09-01 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Theophylline 0.08% And Dextrose 5% In Plastic Container

Condition Name

Condition Name for Theophylline 0.08% And Dextrose 5% In Plastic Container
Intervention Trials
Asthma 22
Chronic Obstructive Pulmonary Disease 8
COPD 8
Lung Diseases 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Theophylline 0.08% And Dextrose 5% In Plastic Container
Intervention Trials
Asthma 20
Lung Diseases 18
Pulmonary Disease, Chronic Obstructive 17
Lung Diseases, Obstructive 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Theophylline 0.08% And Dextrose 5% In Plastic Container

Trials by Country

Trials by Country for Theophylline 0.08% And Dextrose 5% In Plastic Container
Location Trials
United States 138
China 24
Japan 19
Canada 13
United Kingdom 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Theophylline 0.08% And Dextrose 5% In Plastic Container
Location Trials
California 13
Colorado 11
Texas 9
Missouri 8
Tennessee 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Theophylline 0.08% And Dextrose 5% In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Theophylline 0.08% And Dextrose 5% In Plastic Container
Clinical Trial Phase Trials
Phase 4 19
Phase 3 19
Phase 2/Phase 3 5
[disabled in preview] 24
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Theophylline 0.08% And Dextrose 5% In Plastic Container
Clinical Trial Phase Trials
Completed 67
Unknown status 14
Recruiting 10
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Theophylline 0.08% And Dextrose 5% In Plastic Container

Sponsor Name

Sponsor Name for Theophylline 0.08% And Dextrose 5% In Plastic Container
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 10
Boehringer Ingelheim 4
Washington University School of Medicine 4
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Theophylline 0.08% And Dextrose 5% In Plastic Container
Sponsor Trials
Other 118
Industry 30
NIH 13
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
McKinsey
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.